Gilead Sciences (GILD) Payables (2009 - 2026)
Gilead Sciences' Payables came in at $674 million for Q2 2026, up 15.8% from $582 million a year earlier and up 4.5% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Payables was $715 million, down 14.2% from FY2024.
- Payables carries a five-year compound annual growth rate of -30.3% (FY2020 to FY2025).
- Going back by year, Payables was $833 million in FY2024 (+51.5%), $550 million in FY2023 (-39.2%), $905 million in FY2022 (+28.4%) and $705 million in FY2021 (-83.7%).
- The five-year range for quarterly Payables is $537 million (Q2 2024) to $905 million (Q4 2022).
- Year-over-year, Payables increased in five of the last eight quarters, with growth averaging 13.9%.
- The fastest year-over-year change in Payables over five years came in Q3 2024 (growth of 54.1%), and the weakest in Q4 2021 (a decline of 83.7%).
- Business Quant data shows GILD's Payables at $645 million (Q1 2026), $715 million (Q4 2025) and $808 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 674.00 Mn |
| Mar 31, 2026 | 645.00 Mn |
| Dec 31, 2025 | 715.00 Mn |
| Sep 30, 2025 | 808.00 Mn |
| Jun 30, 2025 | 582.00 Mn |
| Mar 31, 2025 | 737.00 Mn |
| Dec 31, 2024 | 833.00 Mn |
| Sep 30, 2024 | 903.00 Mn |
| Jun 30, 2024 | 537.00 Mn |
| Mar 31, 2024 | 622.00 Mn |
| Dec 31, 2023 | 550.00 Mn |
| Sep 30, 2023 | 586.00 Mn |
| Jun 30, 2023 | 622.00 Mn |
| Mar 31, 2023 | 627.00 Mn |
| Dec 31, 2022 | 905.00 Mn |
| Sep 30, 2022 | 614.00 Mn |
| Jun 30, 2022 | 565.00 Mn |
| Mar 31, 2022 | 583.00 Mn |
| Dec 31, 2021 | 705.00 Mn |
| Sep 30, 2021 | 585.00 Mn |
API Access
Gilead Sciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();